Stephen J. Hoffman, Director at ACELRX PHARMACEUTICALS INC (ACRX), bought 1,265,184 shares at $5.00 ($6.2M) on 2011-02-16, disclosed to the SEC on 2011-02-18.
Open-market purchase of $6.2M ACRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 29,241 | $0 | 0.0% |
| 2 | $5.00 | 1,235,943 | $6.2M | 100.0% |
| Total | $4.88 avg | 1,265,184 | $6.2M | 100% |
| Filing → |
| GNCA | BUY | 2014-02-11 | $3.0M | — | Filing → |
| DRNA | BUY | 2014-02-05 | $3.0M | — | Filing → |
| ACRX | BUY | 2012-05-31 | $968K | — | Filing → |